Related Experiment Videos

Long noncoding RNA LINC00337 accelerates the non-small-cell lung cancer progression through inhibiting TIMP2 by

Xiaodong Zhang1, Jun Gong1, Junguo Lu1

  • 1Department of Medical Oncology, Nantong Tumor Hospital Nantong 226006, Jiangsu Province, China.

Insights

This study identifies long noncoding RNA LINC00337 as a key driver in non-small-cell lung cancer (NSCLC) progression. Upregulation of LINC00337 promotes NSCLC cell proliferation and invasion via epigenetic silencing of TIMP2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Long noncoding RNAs (lncRNAs) play crucial roles in cancer development.
  • Non-small-cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
  • The specific functions of many lncRNAs in NSCLC remain largely unexplored.

Purpose of the Study:

  • To investigate the role of the novel lncRNA LINC00337 in non-small-cell lung cancer (NSCLC) tumorigenesis.
  • To elucidate the underlying molecular mechanism of LINC00337 action in NSCLC.
  • To assess LINC00337 as a potential diagnostic biomarker and therapeutic target for NSCLC.

Main Methods:

  • Analysis of LINC00337 expression in NSCLC tissues and cell lines.
  • In vitro functional assays (proliferation, invasion) following LINC00337 manipulation.
  • In vivo tumor growth assays after LINC00337 knockdown.
  • Mechanistic studies involving DNMT1 recruitment and TIMP2 promoter activity.

Main Results:

  • LINC00337 is significantly upregulated in NSCLC tissues and associated with poor patient survival.
  • Overexpression of LINC00337 enhances NSCLC cell proliferation and invasion.
  • Knockdown of LINC00337 inhibits tumor growth in vivo.
  • LINC00337 epigenetically silences TIMP2 by recruiting DNMT1 to its promoter.

Conclusions:

  • LINC00337 acts as an oncogenic lncRNA in NSCLC progression.
  • The LINC00337/DNMT1/TIMP2 axis represents a novel epigenetic regulatory mechanism in NSCLC.
  • LINC00337 holds potential as a predictive biomarker and therapeutic target for NSCLC patients.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K